絞り込み

16533

広告

Inhaled Nitric Oxide in Extremely Premature Neonates With Respiratory Distress Syndrome.

著者 Carey WA , Weaver AL , Mara KC , Clark RH
Pediatrics.2018 Feb 09 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (56view , 0users)

Full Text Sources

Inhaled nitric oxide (iNO) is increasingly prescribed to extremely premature neonates with respiratory distress syndrome (RDS). Most of this off-label use occurs during the first week of life. We studied this practice, hypothesizing that it would not be associated with improved survival.
PMID: 29439205 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード